UNSPSC 51343406: Tilorone hydrochloride

This classification denotes a cholinergic agonist with the molecular formula C25H34N2O3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BJ507J4LKY, chemically known as 2,7-bis-deae-fluorenone but more generally known as tilorone hydrochloride, which bears US NIH Compound Identifier 5475. Most nations, for tariff and trade purposes, schedule tilorone hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, TILORONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Tilorone hydrochloride bears US NLM identifiers UMLS ID C0085800 and NCI Concept Code C72868. SMILES: CCN(CC)CCOC1CCC-2C(C1)C(=O)C3C2CCC(C3)OCCN(CC)CC.CL.CL.

UNSPSC 51343406 Tilorone hydrochloride is a Commodity code that shows little relevant recent activity — the most recently posted state and local opportunities tagged under this code actually solicit naloxone, medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing, none of which are tilorone hydrochloride. The mismatch suggests either miscoding by issuing bodies or that tilorone hydrochloride procurement is not a current driver of state and local market activity. When opportunities do appear under related codes or are tagged broadly to pharmaceutical procurement, they tend to center on emergency response medical supplies (naloxone kits and drug deactivation systems), routine medical and first aid consumables for public safety agencies, and establishment of framework agreements for generic pharmaceuticals and OTC products through state cooperative purchasing vehicles.

The issuing bodies spanning recent pharmaceutical and medical-supply solicitations include county health departments, city fire and rescue divisions, and multistate cooperative purchasing alliances — Seminole County (Florida), the City of Tampa, the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), and the Texas Health and Human Services Commission have all posted activity. Geographic spread includes Florida, Texas, and Minnesota with extensions to Oregon through MMCAP. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida; the City of Tampa's IFB 26P00145 (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000 and designated as a sheltered market for certified Small Local Business Enterprises; and MMCAP's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, requiring vendors to supply through three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act certification.